Work

The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Year: 2019

Type: article

Source: Leukemia

DOI: 10.1038/s41375-019-0529-2

Authors: Steffan T. Nawrocki, Yingchun Han, Valeria Visconte, Bartlomiej Przychodzen, Claudia M. Espitia, James Phillips, Faiz Anwer, Anjali Advani, Hetty E. Carraway, Kevin R. Kelly, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Jennifer S. Carew

Institutions: University of Arizona Cancer Center, Cleveland Clinic, University of Southern California, USC Norris Comprehensive Cancer Center, University of Arizona

Language: English

Topic: Autophagy in Disease and Therapy

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, University of Arizona Cancer Center, National Institutes of Health, National Cancer Institute

Awards: G1361187950, Development of lysosome targeted therapeutics, G1620267363, G1982199368, G2819491483, Endoplasmic reticulum stress and oncoviral therapy, G8335322555, Targeting NEDD8-Mediated Protein Turnover in AML, University of Arizona Cancer Center - Cancer Center Support Grant, G8901572589

OpenAlex ID: W2964499306

FWCI: 4.791

Cites: 11

Cited by: 49

Related to: 10